Skip to main content

How scientific impact scales with funding

So yet another grant proposal bit the dust this week, just an eye roll rather than total devastation, the show must go on. However, I wanted to give this little beauty of a paper some extra air time. It tells us what we may suspect already, that giving the same groups more and more money does not necessarily increase the likelihood of their getting more and more good data. The authors conclude that funding strategies that target diversity, rather than 'excellence' are likely to be more productive.
For me it seems like there are excellent groups doing cutting edge research in their special areas of interest with millions in grant funding, yet we are still seeing very little in the way of therapy for the diseases they work on. It must be time to make a decision to fund small groups with new ideas, and for more than just a year at a time.
To say that an organisation 'funds the best science' suggests we can see into the future...sometimes it's the quirky off-beat ideas that turn out to be the best.

Comments

Popular posts from this blog

Dr. Brad Ebanks - Graduation day!

  Well here we are...in some car park area outside the graduation hall. Just like Brad's PhD... starting in the year 2019/20... it's not ideal, but we made it work! Delighted to have been able to see Brad graduate and to meet his family yesterday! These occasions are the absolute highlight of my academic life - Thank you!

We were able to contribute to two articles appearing this month in Science and Nature Aging!

Epigenetic networks and ageing in 348 mammalian species...including our bats!
New research by a Nottingham academic linking the neurodegenerative disease Parkinson’s to changes in a protein in brain mitochondria is to receive support from a prestigious US funding agency. Dr Lisa Chakrabarti, at The University of Nottingham, will receive $75,000 for a one-year research project from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), which is dedicated to finding a cure for Parkinson’s and funds promising research that could result in new treatments to slow, stop or reverse the progression of the disease. Dr Chakrabarti said: “We are trying to look at mitochondrial biology from a totally different perspective, which could have important implications for Parkinson’s and other neurodegenerative diseases. The funding from The Michael J. Fox Foundation will help us to confirm whether some of the protein changes we see in Parkinson’s are related to disease course.” http://exchange.nottingham.ac.uk/research/parkinsons-study-receives-fu